US regulatory status: approved. Mechanism: Unknown.
- Mechanism
- Unknown
pharma · Metastatic Breast Cancer · Advanced Ovarian Cancer · ALLR
Allarity Therapeutics
Allarity Therapeutics drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Tarpon Springs, USA HQ
2012 Founded
11 Employees
Public company Type
ALLR · NYSE Ticker
Company details
- Status
- Public
- HQ
- Tarpon Springs, USA
- Founded
- 2012
- Employees
- 11
- Programs
- 7
- Drugs
- 4
- Patents
- 1
Allarity Therapeutics pipeline
Portfolio lens on 4 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Allarity Therapeutics drug portfolio — 4 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Allarity Therapeutics in public FDA and regional records.
-
Development asset linked to Allarity Therapeutics in public FDA and regional records.
-
US regulatory status: approved. Molecular target: Tubulin.
- Target
- Tubulin
- Mechanism
- Tubulin inhibitor